Ventas Life Science and Healthcare Real Estate Fund Acquires Trophy Life Science Portfolio in South San Francisco for $1.0 Billion


Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) today announced that the Ventas Life Science and Healthcare Real Estate Fund, L.P. (the “Fund”) has acquired a trophy life science portfolio in the premier South San Francisco life science cluster for $1.0 billion. Ventas is the Sponsor and General Partner of the Fund, which is a perpetual life vehicle focused on investments in core and core plus life science, medical office and senior housing real estate in North America.


“We are pleased to further expand our growing research & innovation footprint into the premier South San Francisco life science cluster with the acquisition of this outstanding lab portfolio,” said Debra A. Cafaro, Ventas Chairman and Chief Executive Officer. “Strong and growing capital flows into the life science sector are accelerating innovation and discovery. These flows support the demand for first class lab space in dynamic markets like South San

Read More

CBRE highlights 6 markets with rapidly growing life science clusters

  • Life science real estate is hot, with the lab space square footage growing by almost 12% across the US in the last year, according CBRE report detailing growth in the largest biotech clusters. 
  • CBRE’s report highlighted the 13 largest biotech clusters and the top 10 emerging clusters, showing how record amounts of funding from the National Insitutes of Health and venture capital are translating to the real estate markets.
  • Business Insider highlighted 6 clusters that are seeing large amounts of growth, whether they’re established but growing very rapidly, like New York City, or they’re emerging, like Pittsburgh and Houston.
  • Visit Business Insider’s homepage for more stories.

Real estate to house pharmaceutical, biotech, and other medical research professionals is growing at a rapid pace and rents continue to rise, a sign that tenant demand can support the increasing attention on life sciences from institutional investors and developers. 

Lab space has grown

Read More